- Home
- SANG vs PRQR Comparison
SANG vs PRQR Comparison
Compare SANG & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- PRQR
- Stock Information
- Founded
- SANG 1984
- PRQR 2012
- Country
- SANG Canada
- PRQR Netherlands
- Employees
- SANG N/A
- PRQR N/A
- Industry
- SANG Computer Software: Programming Data Processing
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- SANG Technology
- PRQR Health Care
- Exchange
- SANG Nasdaq
- PRQR Nasdaq
- Market Cap
- SANG 194.3M
- PRQR 232.8M
- IPO Year
- SANG 2021
- PRQR 2014
- Fundamental
- Price
- SANG $5.50
- PRQR $2.45
- Analyst Decision
- SANG
- PRQR Strong Buy
- Analyst Count
- SANG 0
- PRQR 8
- Target Price
- SANG N/A
- PRQR $8.88
- AVG Volume (30 Days)
- SANG 2.1K
- PRQR 363.6K
- Earning Date
- SANG 11-05-2025
- PRQR 11-06-2025
- Dividend Yield
- SANG N/A
- PRQR N/A
- EPS Growth
- SANG N/A
- PRQR N/A
- EPS
- SANG N/A
- PRQR N/A
- Revenue
- SANG $238,264,000.00
- PRQR $20,129,184.00
- Revenue This Year
- SANG N/A
- PRQR N/A
- Revenue Next Year
- SANG $2.38
- PRQR N/A
- P/E Ratio
- SANG N/A
- PRQR N/A
- Revenue Growth
- SANG N/A
- PRQR 8.65
- 52 Week Low
- SANG $4.08
- PRQR $1.07
- 52 Week High
- SANG $7.99
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- SANG 40.38
- PRQR 65.41
- Support Level
- SANG $5.57
- PRQR $2.13
- Resistance Level
- SANG $6.26
- PRQR $2.33
- Average True Range (ATR)
- SANG 0.11
- PRQR 0.15
- MACD
- SANG -0.01
- PRQR 0.03
- Stochastic Oscillator
- SANG 6.17
- PRQR 90.38
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.